Functionally, the disruption of cis PDL1:CD80 interactions on DCs through point mutations or anti-PDL1 antibodies promotes tumor growth and suppresses autoimmunity in mouse models (Oh et al. 2020, Sugiura et al. 2019), demonstrating the physiological significance of this cis interaction. This evidence concerns the gene CD80 and neoplasm.